Search

Your search keyword '"Teixidó, Montserrat"' showing total 9 results
Start Over Author "Teixidó, Montserrat"
9 results on '"Teixidó, Montserrat"'

1. P-161 Impact of induction treatment on the survival of patients with multiple myeloma candidates for autologous stem cell transplantation: experience of a center

Author

Santoja, Raquel, primary, Rivero, Eugenia, additional, Delgado, Izarbe, additional, Seres, Yasmina, additional, Luaña, Armando, additional, Ferrero, Ainara, additional, Teixidó, Montserrat, additional, Chavez, Carlos, additional, Pimentel, Ana, additional, Tugues, Albert, additional, Marzo, Cristina, additional, Vicente, Eva, additional, Tehas, Maria, additional, Garcia-Cerecedo, Tomas, additional, and Garcia-Guinon, Antonio, additional

Published
2023
Full Text
View/download PDF

4. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

Author

Granell, Miquel, primary, Calvo, Xavier, additional, Garcia-Guiñón, Antoni, additional, Escoda, Lourdes, additional, Abella, Eugènia, additional, Martínez, Clara Mª, additional, Teixidó, Montserrat, additional, Gimenez, Mª Teresa, additional, Senín, Alicia, additional, Sanz, Patricia, additional, Campoy, Desirée, additional, Vicent, Ana, additional, Arenillas, Leonor, additional, Rosiñol, Laura, additional, Sierra, Jorge, additional, Bladé, Joan, additional, and de Larrea, Carlos Fernández, additional

Published
2017
Full Text
View/download PDF

5. Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

Author

Granada, Isabel, primary, Brunet, Salut, additional, Hoyos, Montserrat, additional, Costa, Dolors, additional, Aventín, Anna, additional, Marugán, Isabel, additional, Vallespí, Teresa, additional, Barnues, Marta, additional, Duarte, JJ, additional, Solé, Francesc, additional, Teixidó, Montserrat, additional, Mascaró, M., additional, Llorente, Andreu, additional, Guardia, Ramon, additional, Tormo, Mar, additional, Duarte, Rafael F., additional, Millá, Fuensanta, additional, Esteve, Jordi, additional, Ribera, Josep-Maria, additional, and Sierra, Jordi, additional

Published
2009
Full Text
View/download PDF

6. Systemic prostacyclin in cirrhotic patients

Author

Guarner, Carlos, primary, Soriano, Germán, additional, Such, José, additional, Teixidó, Montserrat, additional, Ramis, Isabel, additional, Bulbena, Oriol, additional, Roselló, Juan, additional, Guarner, Francisco, additional, Gelpi, Emilio, additional, Balanzó, Joaquín, additional, and Vilardell, Francisco, additional

Published
1992
Full Text
View/download PDF

9. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

Author

Granell, Miquel, Calvo, Xavier, Garcia-Guiñón, Antoni, Escoda, Lourdes, Abella Monreal, Eugenia, Martínez, Clara Mª, Teixidó, Montserrat, Gimenez, Mª Teresa, Senín, Alicia, Sanz, Patricia, Campoy, Desirée, Vicent, Ana, Arenillas, Leonor, Rosiñol, Laura, Sierra, Jorge, Bladé, Joan, de Larrea, Carlos Fernández, Universitat Autònoma de Barcelona, and GEMMAC (Grup per l’estudi del mieloma i l’amiloïdosi de Catalunya)

Subjects
Adult, medicine.medical_specialty, Pathology, Plasma Cells, Gastroenterology, Article, Plasma Cell Disorders, Leukemia, Plasma Cell, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Bone Marrow, Internal medicine, Cytology, Humans, Medicine, Platelet, Stage (cooking), Càncer -- Aspectes genètics, Survival analysis, Multiple myeloma, Aged, Retrospective Studies, Aged, 80 and over, Plasma cell leukemia, Creatinine, Platelet Count, business.industry, Mieloma múltiple, Leucèmia, Hematology, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Leukemia, chemistry, 030220 oncology & carcinogenesis, Multiple Myeloma, business, 030215 immunology
Abstract

The presence of circulating plasma cells in patients with multiple myeloma is considered a marker for highly proliferative disease. In the study herein, the impact of circulating plasma cells assessed by cytology on survival of patients with multiple myeloma was analyzed. Wright-Giemsa stained peripheral blood smears of 482 patients with newly diagnosed myeloma or plasma cell leukemia were reviewed and patients were classified into 4 categories according to the percentage of circulating plasma cells: 0%, 1–4%, 5–20%, and plasma cell leukemia with the following frequencies: 382 (79.2%), 83 (17.2%), 12 (2.5%) and 5 (1.0%), respectively. Median overall survival according to the circulating plasma cells group was 47, 50, 6 and 14 months, respectively. At multivariate analysis, the presence of 5 to 20% circulating plasma cells was associated with a worse overall survival (relative risk 4.9, 95% CI 2.6–9.3) independently of age, creatinine, the Durie-Salmon system stage and the International Staging System (ISS) stage. Patients with ≥5% circulating plasma cells had lower platelet counts (median 86×109/L vs. 214×109/L, P

Catalog

Books, media, physical & digital resources
See catalog results